These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 9604135
1. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice. Bruni J. Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135 [Abstract] [Full Text] [Related]
2. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures. Beran R, Berkovic S, Black A, Danta G, Dunne J, Frasca J, Grainger K, Kilpatrick C, McKenzie R, McLaughlin D, Schapel G, Somerville E. Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169 [Abstract] [Full Text] [Related]
3. Gabapentin as adjunctive therapy for partial seizures. Bruni J. Epilepsia; 1999 Oct; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680 [Abstract] [Full Text] [Related]
4. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Sethi A, Chandra D, Puri V, Mallika V. Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470 [Abstract] [Full Text] [Related]
10. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Baulac M, Cavalcanti D, Semah F, Arzimanoglou A, Portal JJ. Seizure; 1998 Feb; 7(1):55-62. PubMed ID: 9548227 [Abstract] [Full Text] [Related]
11. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. McLean MJ, Morrell MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus-Miller L, Bernstein P, Rose-Legatt A. Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221 [Abstract] [Full Text] [Related]
12. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group. Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258 [Abstract] [Full Text] [Related]
15. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development. Sachdeo R, Partiot A, Biton V, Rosenfeld WE, Nohria V, Tompson D, DeRossett S, Porter RJ. Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135 [Abstract] [Full Text] [Related]
16. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety. Morrell MJ. Epilepsia; 1999 Jun; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679 [Abstract] [Full Text] [Related]
17. Lamotrigine extended-release as adjunctive therapy for partial seizures. Naritoku DK, Warnock CR, Messenheimer JA, Borgohain R, Evers S, Guekht AB, Karlov VA, Lee BI, Pohl LR. Neurology; 2007 Oct 16; 69(16):1610-8. PubMed ID: 17938371 [Abstract] [Full Text] [Related]
18. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. Pediatrics; 2006 Aug 16; 118(2):e371-8. PubMed ID: 16847080 [Abstract] [Full Text] [Related]
19. [Clinical studies on gabapentin in Switzerland]. Shokry A. Praxis (Bern 1994); 1996 Jan 23; 85(4):94-8. PubMed ID: 8578060 [Abstract] [Full Text] [Related]
20. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, Garofalo E. Epilepsia; 1999 Aug 23; 40(8):1147-54. PubMed ID: 10448830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]